163 related articles for article (PubMed ID: 21417792)
1. Preemptive dose reduction of warfarin in patients initiating metronidazole.
Holt RK; Anderson EA; Cantrell MA; Shaw RF; Egge JA
Drug Metabol Drug Interact; 2010; 25(1-4):35-9. PubMed ID: 21417792
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
[TBL] [Abstract][Full Text] [Related]
3. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral corticosteroids on chronic warfarin therapy.
Hazlewood KA; Fugate SE; Harrison DL
Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
Edwards HD; Webb RD; Conway SE
Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
[TBL] [Abstract][Full Text] [Related]
7. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
8. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
[TBL] [Abstract][Full Text] [Related]
9. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
Ripley TL; Harrison D; Germany RE; Adamson PB
Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole.
Powers A; Loesch EB; Weiland A; Fioravanti N; Lucius D
J Thromb Thrombolysis; 2017 Jul; 44(1):88-93. PubMed ID: 28417267
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
13. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
Perona S; Ford M; Rindone J
J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
Shah HR; Ledbetter L; Diasio R; Saif MW
Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
[TBL] [Abstract][Full Text] [Related]
16. Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
Howard-Thompson A; Hurdle AC; Arnold LB; Finch CK; Sands C; Self TH
Am J Geriatr Pharmacother; 2008 Mar; 6(1):33-6. PubMed ID: 18396247
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
[TBL] [Abstract][Full Text] [Related]
18. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
[TBL] [Abstract][Full Text] [Related]
19. Retrospective and prospective analyses of the treatment of overanticoagulated patients.
Duong TM; Plowman BK; Morreale AP; Janetzky K
Pharmacotherapy; 1998; 18(6):1264-70. PubMed ID: 9855325
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
